1. Schizophrenia spectrum and related neuropathology

   • Andrea Schmitt
   • Peter Falkai

   Editorial 28 January 2015 Pages: 85 - 86

2. DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive–compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders

   • Hans-Jürgen Möller
   • Borwin Bandelow
   • Wolfgang Maier

   Original Paper 26 August 2014 Pages: 87 - 106

3. What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial

   • Rebecca Schennach
   • Michael Riedel
   • Hans-Jürgen Möller

   Original Paper 27 September 2014 Pages: 107 - 116

   

4. Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia

   • Marta Krzyżanowska
   • Johann Steiner
   • Tomasz Gos

   Original Paper Open access 05 August 2014 Pages: 117 - 126

   

5. Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia

   • S. Kittel-Schneider
   • T. Wobrock
   • A. Reif

   Original Paper 24 June 2014 Pages: 127 - 136

   

6. Complexin2 modulates working memory-related neural activity in patients with schizophrenia

   • Johanna Hass
   • Esther Walton
   • Stefan Ehrlich

   Original Paper 09 October 2014 Pages: 137 - 145

   

7. Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders

   • Stéphane Potvin
   • Ginette Aubin
   • Emmanuel Stip

   Original Paper 13 June 2014 Pages: 147 - 154

8. Evaluation of an integrated care program for schizophrenia: concept and study design

   • L. Kerkemeyer
   • S. Mostardt
   • T. Wobrock

   Original Paper 07 June 2014 Pages: 155 - 162

   

9. Structural connectivity of the salience-executive loop in schizophrenia

   • Sarina J. Iwabuchi
   • Peter F. Liddle
   • Lena Palaniyappan

   Short Communication 26 September 2014 Pages: 163 - 166

   

10. Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment

    • Aline Siqueira Ferreira
    • Nádia Rezende Barbosa Raposo
    • Wagner Farid Gattaz

    Short Communication 15 May 2014 Pages: 167 - 170